University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that UMSOM faculty scientists have been selected as key contractors by the Biomedical Advanced Research and Development Authority (BARDA), for the federal agency’s Radiation Nuclear Animal Model Development program.
New project aims to increase the EU’s ability to combat flavivirus threats
A new project – FLAVIVACCINE – aims to increase the EU’s ability to combat epidemic and pandemic viral threats both in Europe and around the
January 31, 2024